None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants should be able to participate in the trial consistently for 4 months, meeting the following criteria. - 70 years or older - Those visiting outpatient clinics or hospitalized - Pre-frail or frail status determined by one or more categories of the K-Frail scale and one or more categories of the Fried’s phenotype criteria - A person who has given written informed consent to conducting research
Exclusion criteria
Exclusion criteria: - Person in a vulnerable situation as defined by Article 30, Section 1 of the Pharmaceutical Act - Medically identified dementia, Alzheimer’s disease, depression, bipolar disorder, or schizophrenia patients - Patients with incident systemic arrhythmia thrombosis, myocardial infarction, coronary artery bypass graft surgery, or percutaneous coronary intervention within three months of screening - Unstable angina patients with symptoms - Patients identified as heart failure, classified as New York Heart Association Class III and IV - Severe pulmonary hypertension uncontrolled with medication - In case of chest pain, severe breathing difficulties or other safety problems detected during screening or evaluation - Severe haemostatic disorder with platelets less than 75,000 ?
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of frailty status;Change in the number of criteria of Fried’s frailty index | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle mass;SPPB(Short Physical Performance Battery);MMSE(Mini-Mental State Examination);GDS(Geriatric Depression Scale);Other clinical indicators (CBC, total cholesterol, albumin, 25- OH-vitamin D) | — |
Countries
Korea, Republic of
Contacts
Ajou University Hospital